Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Combined Progesterone Administration Versus Single-Route Administration for Luteal Phase Support in IVF: A Systematic Review of Current Evidence

Authors
Vasiliki Dourou 1
Georgios Valsamakis 2
Olga Triantafyllidou 2
Dimitrios Tourlakis 3
Panagiotis Vakas 2
Nikolaos Vlahos 2
1 Institute of Life, IASO General Hospital, Athens, Greece
2 Department of Obstetrics and Gynecology, Aretaieion Ηospital, National and Kapodistrian University of Athens (NKUA), Athens, Greece
3 Department of Gynecologic Oncology, Hygeia Hospital, Athens, Greece
Abstract
Background: Luteal phase support (LPS) with progesterone is essential for successful implantation and early pregnancy maintenance in IVF cycles. Although various administration routes exist (oral, vaginal, intramuscular, subcutaneous), the comparative effectiveness of combined (dual or triple) versus single-route progesterone regimens remains uncertain due to limited high-quality randomized controlled trials. Methods: A systematic review was conducted to evaluate studies comparing pregnancy outcomes in IVF cycles using combined versus single-route progesterone administration for LPS. A comprehensive literature search was performed to identify retrospective, prospective, and randomized controlled studies published in peer-reviewed journals. Data regarding clinical pregnancy, live birth, miscarriage, and implantation rates were collected and synthesized narratively due to heterogeneity among included studies. Results: Most studies did not demonstrate statistically significant differences in outcomes between single-route and combined progesterone regimens, particularly when dydrogesterone was included. However, certain combinations, especially those involving oral dydrogesterone alongside vaginal or intramuscular progesterone, were associated with improved live birth and clinical pregnancy rates. Despite these encouraging findings, the lack of adequately powered RCTs and the methodological variability among studies limit the generalizability of the results. Conclusion: While single-route progesterone administration remains effective for luteal phase support in IVF cycles, emerging evidence suggests that individualized combined regimens may enhance pregnancy outcomes. The physiological rationale for combined administration, offering both systemic and local endometrial support, is compelling. Further well-designed randomized controlled trials with standardized protocols are necessary to establish evidence-based guidelines for optimal LPS.
Keywords
Combined administration
IVF
Live birth rate
Luteal phase support
Pregnancy rates
Progesterone administration
Sun H, Gong TT, Jiang YT, Zhang S, Zhao YH, Wu QJ. Global, regional, and national prevalence and disability-adjusted life-years for infertility in 195 countries and territories, 1990-2017: results from the global burden of disease study 2017. Aging (Albany NY). 2019;11(23):10952-91.
Ombelet W. WHO fact sheet on infertility gives hope to millions of infertile couples worldwide. Facts Views Vis Obgyn. 2020;12(4):249-51.
Wang J, Liu C, Fujino M, Tong G, Zhang Q, Li XK, et al. Stem cells as a resource for treatment of infertility-related diseases. Curr Mol Med. 2019;19(8):539-46.
Graham ME, Jelin AC, Hoon AH Jr, Wilms Floet AM, Levey E, Graham EM. Assisted reproductive technology: short- and long-term outcomes. Dev Med Child Neurol. 2023;65(1):38-49.
Gnoth C, Maxrath B, Skonieczny T, Friol K, Godehardt E, Tigges J. Final ART success rates: a 10-year survey. Hum Reprod. 2011;26(8):2239-46.
Haas DM, Hathaway TJ, Ramsey PS. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database Syst Rev. 2019;10(10):CD003511.
Kumar P, Magon N. Hormones in pregnancy. Niger Med J. 2012;53(4):179-83.
Bulletti C, Bulletti FM, Sciorio R, Guido M. Progesterone: the key factor of the beginning of life. Int J Mol Sci. 2022;23(22):14138.
Hughes GC, Clark EA, Wong AH. The intracellular progesterone receptor regulates CD4+ T cells and T cell-dependent antibody responses. J Leukoc Biol. 2013;93(3):369-75.
Deligdisch L. Hormonal pathology of the endometrium. Mod Pathol. 2000;13(3):285-94.
Pabuccu E, Pabuccu R, Gurgan T, Tavmergen E. Luteal phase support in fresh and frozen embryo transfer cycles. J Gynecol Obstet Hum Reprod. 2020:101838.
Polat M, Mumusoglu S, Bozdag G, Ozbek IY, Humaidan P, Yarali H. Addition of intramuscular progesterone to vaginal progesterone in hormone replacement therapy in vitrified-warmed blastocyst transfer cycles. Reprod Biomed Online. 2020;40(6):812-8.
Di Guardo F, Midassi H, Racca A, Tournaye H, De Vos M, Blockeel C. Luteal phase support in IVF: comparison between evidence-based medicine and real-life practices. Front Endocrinol (Lausanne). 2020;11:500.
Casarramona G, Lalmahomed T, Lemmen C, Eijkemans M, Broekmans F, Cantineau A, et al. The efficacy and safety of luteal phase support with progesterone following ovarian stimulation and intrauterine insemination: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:960393.
Almohammadi A, Raveendran A, Black M, Maheshwari A. The optimal route of progesterone administration for luteal phase support in frozen embryo transfer: a systematic review. Arch Gynecol Obstet. 2023;308(2):341-50.
Toriumi R, Horikawa M, Sato C, Shimamura N, Ishii R, Terashima M, et al. The addition of dydrogesterone improves outcomes in women with low progesterone levels receiving vaginal progesterone alone in HRT-FET cycles. Reprod Med Biol. 2023;22(1):e12511.
Jalaliani S, Davar R, Akbarzadeh F, Emami F, Eftekhar M. Addition of intramuscular to vaginal progesterone for luteal phase support in fresh embryo transfer cycles: a cross-sectional study. Int J Reprod Biomed. 2022;20(9):745-52.
Pabuccu EG, Pabuccu R, Evliyaoglu Ozdegirmenci O, Bostancı Durmus A, Keskin M. Combined intramuscular and vaginal progesterone versus vaginal progesterone for luteal support in cleavage-stage embryo transfer cycles. Gynecol Endocrinol. 2016;32(5):366-9.
Vuong LN, Pham TD, Le KTQ, Ly TT, Le HL, Nguyen DTN, et al. Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective cohort study. Hum Reprod. 2021;36(7):1821-31.
Vidal A, Dhakal C, Werth N, Weiss JM, Lehnick D, Kohl Schwartz AS. Supplementary dydrogesterone is beneficial as luteal phase support in artificial frozen-thawed embryo transfer cycles compared to micronized progesterone alone. Front Endocrinol (Lausanne). 2023;14:1128564.
Gawron IM, Chrostowski B, Derbisz K, Jach R, Pietrus M. Comparison of dydrogesterone plus progesterone gel with subcutaneous aqueous progesterone plus progesterone gel for luteal phase support in IVF cycles after previous failure. Ginekol Pol. 2023. [a head of print].
Devine K, Richter KS, Widra EA, McKeeby JL. Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with Endometrin have inferior ongoing pregnancy rates: results from the planned interim analysis of a three-arm randomized controlled noninferiority trial. Fertil Steril. 2018;109(2):266-75.
Xu H, Zhang XQ, Zhu XL, Weng HN, Xu LQ, Huang L, et al. Comparison of vaginal progesterone gel combined with oral dydrogesterone versus intramuscular progesterone for luteal support in hormone replacement therapy-frozen embryo transfer cycle. J Gynecol Obstet Hum Reprod. 2021;50(7):102110.
Gari S, Al-Jaroudi D. Adding Weekly Intramuscular Progesterone to a Twice Daily Vaginal Progesterone Capsule for Luteal Phase Support in IVF/ ICSI Cycles Results in Similar Live Birth Rates. JBRA Assist Reprod. 2022;26(1):33-7.
Asoglu MR, Celik C, Karakis LS, Findikli N, Gultomruk M, Bahceci M. Comparison of daily vaginal progesterone gel plus weekly intramuscular progesterone with daily intramuscular progesterone for luteal phase support in single, autologous euploid frozen-thawed embryo transfers. J Assist Reprod Genet. 2019;36(7):1481-7.
Wang Y, He Y, Zhao X, Ji X, Hong Y, Wang Y, et al. Crinone gel for luteal phase support in frozen-thawed embryo transfer cycles: a prospective randomized clinical trial in the Chinese population. PLoS One. 2015;10(7):e0133027.
Simon V, Robin G, Keller L, Ternynck C, Jonard S, Robin C, et al. Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study. Front Endocrinol (Lausanne). 2022;13:1039579.
Journal of Reproduction & Infertility
Volume 27, Issue 1
Winter 2026
Pages 3-9